Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Bohm M, Xu R, Zhang Y, Varma S, et al. Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease. Aliment Pharmacol Ther 2020;52:669-681.
PMID: 32656800


Privacy Policy